Leiman, David A.Maratt, Jennifer K.Ketwaroo, Gyanprakash A.2021-01-282021-01-282020-11-23Leiman, D. A., Maratt, J. K., & Ketwaroo, G. A. (2020). AGA Institute Quality Measure Development for the Diagnosis and Management of COVID-19. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.11.0391528-00120016-5085https://hdl.handle.net/1805/25068This document presents the official recommendations of the American Gastroenterological Association (AGA) regarding quality measures related to the diagnosis and management of the novel coronavirus, SARS-CoV-2. The current report outlines the process by which the Quality Committee (QC) evaluates guidance statements published by the AGA’s Clinical Guidelines Committee (CGC) to inform measure development. The recommendations discussed in this report relate to what remains an unprecedented event in contemporary history with unique challenges for CGC guidance-related measure development. The following recommendations were developed by the QC in consultation with the CGC. Their development was fully funded by the AGA Institute, with no additional outside funding.en-USIUPUI Open Access PolicyCOVID-19American Gastroenterological Association (AGA)RecommendationsGuidanceBest PracticesArticle